Growing interest in Redbiotec’s CMV program

Redbiotec has been selected to present its CMV Vaccine program at the CMV 2012 Meeting in San Francisco starting October 31. Pharma companies including Novartis, Sanofi Pasteur, MedImmune, Boehringer Ingelheim with leading CMV activities will also join the meeting.